This mutation is so heavily associated with cancer because it allows BRAF to be activated independently of RAS, leading to constant BRAF activation and therefore constant activation of the RAS-RAF-MEK-ERK phosphorylation cascade [57]. Here, MAPK1 is linked to cancer.